1.5
Cellular Adaptation III: Hyperplasia
Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimul…
Hyperplasia refers to an increase in the number of cells within a tissue or organ, typically driven by elevated cell division to support tissue repair and regeneration.
Tissues such as the epidermis, intestinal epithelium, and bone marrow possess strong hyperplastic potential, whereas bone, cartilage, and smooth muscle have limited capacity for hyperplasia.
Hyperplasia generally arises through two mechanisms. One mechanism involves stimulation by growth factors or hormones. After cell injury, these signals prompt surviving cells to re-enter the cell cycle and begin dividing.
The other mechanism depends on the activation of tissue stem or progenitor cells, which generate mature cells to replace damaged ones.
Hyperplasia may be physiologic or pathologic.
Physiologic hyperplasia is a normal response that maintains tissue balance, such as the endometrial proliferation during the menstrual cycle.
Pathologic hyperplasia results from excessive stimulation, such as thyroid hyperplasia caused by chronic TSH elevation in iodine deficiency.
View the full transcript and gain access to JoVE Core videos
Q1: What is hyperplasia and how does it differ from other cellular changes?
Hyperplasia is an increase in the number of cells within a tissue or organ due to enhanced cell division. Unlike cellular adaptation i introduction and atrophy, which involves cell size changes or reduction, hyperplasia maintains cell size while increasing cell count through mitosis to support tissue repair and regeneration.
Q2: Which tissues have the greatest capacity for hyperplasia?
Tissues with high hyperplastic potential include the epidermis, intestinal epithelium, bone marrow, and fibroblasts. These tissues readily regenerate in response to injury or physiologic demand. In contrast, bone, cartilage, and smooth muscle show limited capacity for hyperplasia due to their structural roles and reduced regenerative capacity, making them less responsive to hyperplastic stimuli.
Q3: How do growth factors and hormones trigger hyperplasia after tissue injury?
Following tissue damage, growth factors and hormones stimulate surviving cells to re-enter the cell cycle and proliferate. This signal-driven mechanism restores tissue integrity by prompting dormant cells to divide and replace lost or damaged cells. The surviving cells respond to these chemical signals by resuming mitosis and generating new tissue mass.
Q4: What role do stem and progenitor cells play in hyperplasia?
Tissue stem or progenitor cells generate new mature cells to replace damaged ones through activation. In the liver, hepatocytes primarily regenerate after injury, while liver progenitor cells mainly contribute during severe or chronic injuries when hepatocyte division is insufficient. This dual mechanism ensures tissue regeneration across varying injury severities.
Q5: What is the difference between physiologic and pathologic hyperplasia?
Physiologic hyperplasia is a normal, controlled response maintaining tissue balance, such as endometrial proliferation during the menstrual cycle. Pathologic hyperplasia results from excessive stimulation, such as thyroid hyperplasia from chronic TSH elevation, and may increase cancer risk. Pathologic hyperplasia represents an abnormal adaptive response to prolonged or excessive stimuli.
Q6: What are examples of compensatory hyperplasia in the body?
Compensatory hyperplasia restores tissue after loss or injury through increased cell division. Examples include liver regeneration after partial removal, callus formation during bone healing, wound healing through epithelial proliferation, and increased bone marrow activity to replace blood cells. These responses demonstrate the body's capacity to restore tissue mass and function.
Q7: How does hormonal hyperplasia differ from other types of hyperplasia?
Hormonal hyperplasia occurs specifically in response to hormonal stimulation, such as breast growth during puberty and pregnancy or endometrial proliferation during the menstrual cycle. Unlike compensatory hyperplasia triggered by tissue loss, hormonal hyperplasia is driven by circulating hormone levels and represents a physiologic adaptation to normal endocrine signaling.